{"?xml":{"@version":"1.0"},"edm:RDF":{"@xmlns:dc":"http://purl.org/dc/elements/1.1/","@xmlns:edm":"http://www.europeana.eu/schemas/edm/","@xmlns:wgs84_pos":"http://www.w3.org/2003/01/geo/wgs84_pos","@xmlns:foaf":"http://xmlns.com/foaf/0.1/","@xmlns:rdaGr2":"http://rdvocab.info/ElementsGr2","@xmlns:oai":"http://www.openarchives.org/OAI/2.0/","@xmlns:owl":"http://www.w3.org/2002/07/owl#","@xmlns:rdf":"http://www.w3.org/1999/02/22-rdf-syntax-ns#","@xmlns:ore":"http://www.openarchives.org/ore/terms/","@xmlns:skos":"http://www.w3.org/2004/02/skos/core#","@xmlns:dcterms":"http://purl.org/dc/terms/","edm:WebResource":[{"@rdf:about":"http://www.dlib.si/stream/URN:NBN:SI:doc-V4W0FEHM/756d0156-84c1-455e-a38c-864cc101662d/PDF","dcterms:extent":"534 KB"},{"@rdf:about":"http://www.dlib.si/stream/URN:NBN:SI:doc-V4W0FEHM/4debf10d-c320-4dc7-88fb-59762c5f2bfd/TEXT","dcterms:extent":"0 KB"}],"edm:TimeSpan":{"@rdf:about":"2008-2025","edm:begin":{"@xml:lang":"en","#text":"2008"},"edm:end":{"@xml:lang":"en","#text":"2025"}},"edm:ProvidedCHO":{"@rdf:about":"URN:NBN:SI:doc-V4W0FEHM","dcterms:isPartOf":[{"@rdf:resource":"https://www.dlib.si/details/URN:NBN:SI:spr-FQ9JBKO1"},{"@xml:lang":"sl","#text":"Rehabilitacija (Ljubljana)"}],"dcterms:issued":"2023","dc:creator":["Ciber, Nataša","Kovačec Hermann, Teja","Novak, Tina"],"dc:format":[{"@xml:lang":"sl","#text":"letnik:22"},{"@xml:lang":"sl","#text":"str. 11-19"},{"@xml:lang":"sl","#text":"številka:supl. 1"}],"dc:identifier":["COBISSID_HOST:152750083","ISSN:2232-545X","URN:URN:NBN:SI:doc-V4W0FEHM"],"dc:language":"sl","dc:publisher":{"@xml:lang":"sl","#text":"Univerzitetni rehabilitacijski inštitut Republike Slovenije - Soča"},"dc:subject":[{"@xml:lang":"en","#text":"botulinum toxin"},{"@xml:lang":"sl","#text":"Cerebral Palsy"},{"@xml:lang":"sl","#text":"cerebralna paraliza"},{"@xml:lang":"sl","#text":"Child"},{"@xml:lang":"en","#text":"functional abilities"},{"@xml:lang":"sl","#text":"funkcijske sposobnosti"},{"@xml:lang":"sl","#text":"gibljivost"},{"@xml:lang":"sl","#text":"otrok"},{"@xml:lang":"sl","#text":"rehabilitation"},{"@xml:lang":"en","#text":"spasticity"},{"@xml:lang":"sl","#text":"spastičnost"},{"@xml:lang":"sl","#text":"toksin botulina"},{"@xml:lang":"en","#text":"walking"}],"dcterms:temporal":{"@rdf:resource":"2008-2025"},"dc:title":{"@xml:lang":"sl","#text":"Učinkovitost kombinacije toksina botulina in fizioterapevtskih postopkov za izboljšanje telesnih funkcij in zgradb pri otrocih s cerebralno paralizo| pregled literature| The effectiveness of the combination of botulinum toxin and physiotherapeutic procedures for improving body functions and structures in children with cerebral palsy| literature review|"},"dc:description":[{"@xml:lang":"sl","#text":"Introduction: Spasticity prevents normal movement and can lead to the development of contractures in children with cerebral palsy. Botulinum toxin type A is an effective and safe way of treating spasticity and reducing its influence on the range of movements in the joints and thus enabling more correct movement patterns. Aim of the study was to review the effectiveness of treatment with botulinum toxin in combination with physiotherapy on the improvement of function of children with cerebral palsy compared to physiotherapy alone. Methods: PubMed, PEDro and Ovid databases were reviewed. The search covered all publications up to February 2023. We also added relevant studies from the Cochrane systematic review literature list. Results: Nine randomised controlled trials published between 2000 and 2022 were included in the review. Children with a spastic form of cerebral palsy were included in the research. The average of the subjects was from 1.3 years to 9.5 years. Statistically significant improvement was reported for muscle tone, range of motion, gait pattern, and gross motor skills. The typical improvement in outcome measures was short-lived, mostly lasting only two to 12 weeks. Conclusion: The combination of botulinum toxin type A and physiotherapy is effective in reducing muscle tone and improving range of motion. In botulinum toxin treatment, patient selection and treatment time are crucial. Younger children are said to be the most suitable candidates. Recent research highlights the concerns about the harmful effects of botulinum toxin type A on muscle morphology"},{"@xml:lang":"sl","#text":"Izhodišča: Spastičnost onemogoča normalno gibanje in lahko vodi v razvoj kontraktur pri otrocih s cerebralno paralizo. Toksin botulina tipa A je učinkovit in varen način zdravljenja spastičnosti, saj z zmanjševanjem le-te v mišicah vplivamo na primeren obseg gibov v sklepih ter tako omogočamo pravilnejše vzorce gibanja. Pregledati smo želeli izsledke raziskav o učinkovitosti aplikacije toksina botulina v kombinaciji s fizioterapevtsko obravnavo na izboljšanje telesnih funkcij in zgradb otrok s cerebralno paralizo v primerjavi s fizioterapijo. Metode: Pregledali smo podatkovne zbirke PubMed, PEDro in Ovid. Iskanje je zajelo vse objave do februarja 2023. K temu smo dodali še ustrezne raziskave s seznama literature Cochrane sistematičnega pregleda. Rezultati: V pregled smo vključili devet randomiziranih kontroliranih raziskav, ki so bile objavljene med letoma 2000 in 2022. V raziskave so bili vključeni otroci s spastično obliko cerebralne paralize. Povprečna starost preiskovancev je bila od 1,3 leta do 9,5 leta. Avtorji so poročali o statistično značilnem izboljšanju mišičnega tonusa, obsega gibljivosti, vzorca hoje in grobe gibalne sposobnosti. Značilno izboljšanje spremenljivk je bilo kratkotrajno, večinoma le od dveh do 12 tednov. Zaključek: Kombinacija toksina botulina tipa A in fizioterapije je učinkovita za zmanjšanje mišičnega tonusa in izboljšanje obsega gibljivosti. Kljub temu pa se zdi, da v klinični praksi prihaja do slabšega prenosa osnovnega učinka zdravljenja s toksinom botulina tipa A v funkcijo (vsakodnevne aktivnosti). Pri zdravljenju s toksinom botulina sta izbira pacienta in čas zdravljenja ključnega pomena. Najbolj primerni kandidati naj bi bili mlajši otroci. Z novejšimi raziskavami v ospredje vedno bolj prihajajo tudi pomisleki glede možnih škodljivih učinkov toksina botulina tipa A na morfologijo mišic"}],"edm:type":"TEXT","dc:type":[{"@xml:lang":"sl","#text":"znanstveno časopisje"},{"@xml:lang":"en","#text":"journals"},{"@rdf:resource":"http://www.wikidata.org/entity/Q361785"}]},"ore:Aggregation":{"@rdf:about":"http://www.dlib.si/?URN=URN:NBN:SI:doc-V4W0FEHM","edm:aggregatedCHO":{"@rdf:resource":"URN:NBN:SI:doc-V4W0FEHM"},"edm:isShownBy":{"@rdf:resource":"http://www.dlib.si/stream/URN:NBN:SI:doc-V4W0FEHM/756d0156-84c1-455e-a38c-864cc101662d/PDF"},"edm:rights":{"@rdf:resource":"http://rightsstatements.org/vocab/InC/1.0/"},"edm:provider":"Slovenian National E-content Aggregator","edm:intermediateProvider":{"@xml:lang":"en","#text":"National and University Library of Slovenia"},"edm:dataProvider":{"@xml:lang":"sl","#text":"Univerzitetni rehabilitacijski inštitut RS – Soča"},"edm:object":{"@rdf:resource":"http://www.dlib.si/streamdb/URN:NBN:SI:doc-V4W0FEHM/maxi/edm"},"edm:isShownAt":{"@rdf:resource":"http://www.dlib.si/details/URN:NBN:SI:doc-V4W0FEHM"}}}}